Thai Otsuka Pharmaceutical is the first overseas operation of Otsuka Group, Japan, founded in 1973. In line with our corporate philosophy, “Otsuka-people creating new products for better health worldwide”, we have overcome a variety of difficulties and cooperate with Thai physicians to research and develop the Enteral Nutrition (Medical Food), be recognized as leading provider of intravenous solutions, be provided various innovative pharmaceutical products developed by Otsuka Group. We do not only aim to be a company of creative individuals, but we are also passionately building a company devoted to better health. With the invention and development of products, specifically on Medical Foods, and the establishment of high manufacturing standards, our products have been internationally recognized and can be exported to many countries such as Japan, Taiwan, Hong Kong and Indonesia.
Contact details
Thai Otsuka Pharmaceutical Co., Ltd.
15th Floor, Unit no.1501-1502, United Center Building,
323 Silom Road, Silom, Bangrak, Bangkok 10500, Thailand
Tel: 02-401-9560
Fax: 02-401-9561
Website: http://www.thai-otsuka.co.th/
The biggest pharma stories from Southeast Asia, including GSK’s new HPF manufacturing investment, license suspensions for Samco Farma and Ciubros Farma after Indonesia’s acute kidney injury crisis, Kalbe’s Aventis share…
Through compassionate use programs patients suffering from critical, life-threatening conditions can access potential life-saving therapeutic options which have not been formally approved by the responsible health authority in an ethical…
Takeda’s Soon Yee Chow and Helene Sou, writing in the September 2022 edition of DIA’s Global Forum magazine, outline how digitalisation initiatives, if properly enacted, can help the ASEAN region…
Writing in the September edition of DIA’s Global Forum magazine, Rosilawati Ahmad of Malaysia’s National Pharmaceutical Regulatory Agency; Tharnkamol Chanprapaph of the Thai FDA; and Samvel Azatyan, Valerio Reggi, and…
The latest from the pharma industry in Southeast Asia, including underwhelming results from Kalbe Pharma, Indonesia’s largest pharma company; Novavax’s vaccine manufacturing plans in the Philippines; the promising future of…
PharmaBoardroom’s latest report: Healthcare & Life Sciences Review: Thailand is available for download now. Thailand is in the midst of an economic transformation with healthcare at its heart. With four years…
Shinsuke Yuasa, president of Thai Otsuka discusses the importance of Thailand for Otsuka as its first overseas market back in 1973. Yuasa goes on to highlight how the affiliate is…
Thailand country managers from three of the world’s largest medtech firms outline the level of innovation they are able to bring to the Thai market, how their technology is helping…
Nico Form-Zuellig, general manager of Interthai Pharmaceutical Manufacturing, shares his thoughts on the Thai pharmaceutical market as a newcomer to the country and goes on to elaborate on the company’s…
Philippe Pedeboscq, managing director of Siemens Healthineers, shares his impressions after taking the lead of the company’s Thailand affiliate two years ago. Pedeboscq goes on to explain his strategic mission…
Every generation of Novo Nordisk’s insulin portfolio is currently on the Thai Market and the affiliate is one of the fastest-growing pharma multinationals in Thailand. Upon this solid foundation, Novo…
Nares Damrongchai has been the CEO of the Thailand Center of Excellence for Life Science (TCELS) since its foundation in 2004. After seven years onboard, he discusses the organization’s progress…
See our Cookie Privacy Policy Here
